Dragon Pharma
Tirze-Pep 5mg
$99.00
- Active Substance: Tirzepatide
- Concentration: 5 mg per vial
- Pack Size: Lyophilized injectable vial
- Manufacturer: Dragon Pharma
- Brand Name: Tirze-Pep
- Molecular Formula: C225H348N56O64
- Molecular Weight: 4813.5 g/mol
- Synonyms: LY3298176, GLP-1/GIP dual agonist
Estimated Delivery: 12-26 Days (International), 3-6 Days (United States)
Return within 45 Days of purchase. Duties & taxes are non-refundable.
Tirze-Pep 5 mg by Dragon Pharma is a synthetic research peptide formulation of Tirzepatide, a dual incretin receptor agonist that mimics the effects of both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). It is currently being studied for its ability to regulate insulin response, reduce body fat, and suppress appetite in metabolic health models. Delivered in a lyophilized 5 mg injectable vial, Tirze-Pep is designed for research institutions exploring modern obesity and endocrine pathways.
Mechanism of Action
Tirzepatide operates by activating both GIP and GLP-1 receptors, which are critical incretins involved in regulating insulin secretion and appetite signaling. Upon activation, Tirzepatide enhances insulin sensitivity in response to elevated glucose, delays gastric emptying, and communicates with the hypothalamus to reduce food cravings. These actions contribute to both improved glycemic control and significant reductions in body weight.
Preclinical studies have shown that Tirzepatide also influences lipid metabolism, lowers fasting blood glucose, and may help modulate inflammatory markers. Its unique dual action distinguishes it from traditional GLP-1 agonists and may offer broader metabolic benefits. Dragon Pharma's Tirze-Pep formulation ensures research-grade purity for laboratory use.
Key Features & Benefits
- Dual Receptor Action: Simultaneously activates GIP and GLP-1 pathways for enhanced metabolic response.
- Potent Appetite Suppression: Helps reduce caloric intake by modulating hunger signals in the brain.
- Fat Loss Support: Shown to significantly decrease visceral and subcutaneous fat in clinical research.
- Metabolic Enhancer: Improves insulin sensitivity and lowers fasting glucose levels.
- Research-Grade Purity: High-quality peptide produced by Dragon Pharma for laboratory applications.
Legal Disclaimer
Disclaimer: Tirze-Pep (Tirzepatide) is intended for scientific research only. It is not approved for human consumption, therapeutic use, or self-administration. Laboratory handling is required under controlled conditions.
Frequently Asked Questions
Tirzepatide is a dual GIP and GLP-1 receptor agonist peptide studied for its effects on insulin regulation, fat loss, and metabolic health.
It works by stimulating two incretin receptors (GIP and GLP-1), enhancing insulin sensitivity, slowing digestion, and reducing appetite, leading to improved glycemic control and body weight reduction.
Hair loss is not commonly associated with Tirzepatide. Most studies have not reported it as a significant side effect, but all research is ongoing.
Appetite suppression is often noted within 1–2 weeks in study participants, though individual response may vary by protocol.
Some subjects in trials have reported mild fatigue, especially early in the protocol. However, energy levels typically stabilize as the body adjusts.
Related Products
